Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2006-09-12
2006-09-12
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S471000, C424S482000, C514S772000, C514S772200
Reexamination Certificate
active
07105180
ABSTRACT:
The invention relates to a novel benzimidazole formulation and to a process for its production. The benzimidazole formulation comprises a layer comprising the benzimidazole compound together with an acidic reacting compound.
REFERENCES:
patent: 3712886 (1973-01-01), Koyanagi et al.
patent: 4370313 (1983-01-01), Davies
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 5232706 (1993-08-01), Palomo Coll
patent: 5626875 (1997-05-01), Ballester Rodes et al.
patent: 31 51 196 (1981-12-01), None
patent: 32 33 764 (1982-09-01), None
patent: 0 005 129 (1979-10-01), None
patent: 0 122 815 (1984-10-01), None
patent: 0 124 495 (1984-11-01), None
patent: 0 237 200 (1987-09-01), None
patent: 0 244 380 (1987-11-01), None
patent: 0 247 983 (1987-12-01), None
patent: 0 342 522 (1989-11-01), None
patent: 0 519 144 (1991-06-01), None
patent: 0 773 025 (1997-05-01), None
patent: 0 519 144 (1997-08-01), None
patent: 1190387 (1970-05-01), None
patent: 1 589 982 (1981-05-01), None
patent: 0646006 (1997-03-01), None
patent: 58-109413 (1983-06-01), None
patent: 59-20219 (1984-02-01), None
patent: 9132522 (1996-09-01), None
patent: 101826 (1996-02-01), None
patent: WO 92/22284 (1992-12-01), None
patent: WO 93/25204 (1993-12-01), None
patent: WO 96/37195 (1996-11-01), None
patent: WO 98/19668 (1998-05-01), None
patent: WO 98/40069 (1998-09-01), None
patent: WO 98/52564 (1998-11-01), None
patent: WO 99/48498 (1999-09-01), None
patent: 74/3391 (1974-05-01), None
“Introduction of Our Four Excipients”,Technical BulletinShin-Etsu Chemical Co., Ltd. (1975).
“Hydropoxypropyl Methylcellulose TC-5”, Shin-Etsu Chemical Co., Ltd., 1-15 (1975).
Lee, JC, “Cellulose Acetate Phthalate”,Handbook of Pharmaceutical Excipients, 2ndEdition, 91-93 (1994).
Shek, E. et al., “Cellulose Acetate Phthalate”,Handbook of Pharmaceutical Excipients, 51-52 (1986).
Monaco, A.L. et al., “Hydropoxypropyl Methylcellulose Phthalate”,Handbook of Pharmaceutical Excipients, 141-144 (1986).
Holstills, E.A. et al., “Polymethacrylates”,Handbook of Pharmaceutical Excipients, 214-216 (1986).
Ellis, J.R. et al., “Chapter 12-Tablet Coating”,The Theory and Practice of Industrial Pharmacy, 2ndEdition, 359-386 (1976).
“The National Formulary—16thEdition”,The United States Pharmacopeia, 21stRevision, 1242-1246 (1985).
Lieberman et al., “Sugar-Coating Techniques”,Pharmaceutical Dosage Forms, vol. 3, 85-87 (1982).
Stachura, J. et al.,Hepato-gastroenterol., 30, 205-210 (1983).
Lind et al.,Gut, 24, 270-276 (1983).
Shukla, AJ, “Polymethacrylates”,Handbook of Pharmaceutical Excipients, 2ndEdition, 362-366 (1994).
Rackur, G. et al.,Biochemical and Biophysical Research Communications, 128(1), 477-485 (1985).
Tsuda, et al. “Basic Course of Drug Development XI”,The Production of Pharmaceuticals, vol. 1, 1-57 (1971)—English Translation.
Pilbrant, A. et al.,Scandinavian Journal of Gastroenterology, 20(108), 113-120 (1985).
“Introduction and Uses of TC-5”,Hydroxypropyl Methulcellulose TC-5, 1-3 (1975).
Kubo, et al., Japan Industrial Technology Federation, “Coating of Drugs”,Up-to-date Pharmaceutical Technology Series, No. 1, 1-3 (1969).
International Search Report, PCT/EP 00/12286, Dec. 6, 2000.
Schepky, “Stabilisierung von physikalischen Eigenschaften fester Arzneiformen”,Stabilisierungstechnologie Wege zur haltbaren Arzneiform, 45-64 (1986).
Bauer, “Ubersicht uber Inkompatibilitatsmoglichkeiten, insbesondere bei der Umhullung von Arzneizubereitungen”,Deutsche Apotheker Zeitung, 118(4) 125-130 (1978).
Klotz, U., “Klinische Pharmakologie von 5-Aminosalicylsaure”,Therapie chronisch entzundlicher Darmerkrankungen, 221-227 (1985).
Dechesne et al., Ubersetzung von Auszugen ausJ. Pharm., Belg., 37(4), 273-282 (1982).
Lehmann et al., “Anwendung waBriger Kunststoffdispersionen zum Uberziehen von Arzneiformen”,Pharm. Ind., 34(11a), 894-899 (1972).
“Qualitatsnormen und Analysenmethoden fur Eudragit L 30 D”,Röhm Pharma., (1982).
Bauer et al., “Studien uber waBrige Applikationsformen einiger synthetischer Polymere fur dunndarmlosliche Filmuberzuge”Pharm. Ind., 41(12), 1203-1207 (1979).
Voight et al.,Lehrbach der pharmazeutischen Technologie, 218 ( Verlag Chemie, 1979).
Lehmann et al.,Praktikum des Lack-Dragierens, 1-13 (Rohm Pharma 1983).
Bauer et al., “Kombatibilitat und Stabilitat”,Pharmazeutische Technologie, 571-593 (1986).
List et al.,Hagers Handbuch der Pharmazeutischen Praxis, 760 (1971).
Hengels, “Omeprazol: Wirkungen und Nebenwirkungen”Z. Gastroenterologie, 22, 241-243 (1984).
Greenwood N.N., Earnshaw A.,Chemistry of the Elements, Department of Inorganic and Structural Chemistry, University of Leeds, U.K., pp. 598-599 (Pergamon Press, 1984).
Hartley Michael G.
Ratiopharm GmbH
Reed Smith LLP
Young Micah-Paul
LandOfFree
Stable galenic preparations comprising a benzimidazole and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable galenic preparations comprising a benzimidazole and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable galenic preparations comprising a benzimidazole and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607268